Medical Care
Global Oncology Based Preclinical CRO Market Research Report 2025
- Apr 16, 25
- ID: 189923
- Pages: 90
- Figures: 85
- Views: 28
The global market for Oncology Based Preclinical CRO was valued at US$ 480 million in the year 2024 and is projected to reach a revised size of US$ 1075 million by 2031, growing at a CAGR of 12.4% during the forecast period.
Preclinical research refers to before testing a drug in people, researchers must find out whether it has the potential to cause serious harm, also called toxicity. A Preclinical CRO, or preclinical contract research organization, provides the experience, knowledge, and skill required to take a pharmaceutical product or medical device from the drawing board to distribution. This journey entails a plethora of activities that involve scientists, medical personnel, administrators, governmental and industry liaisons, marketing experts, and a host of other technical and creative individuals. Rarely is this unique combination of credentials and craft already present within a sponsoring organization. The CRO industry emerged to fill this much-needed role, to provide the expertise required to bring a pharmaceutical product or medical device into the marketplace as quickly and smoothly as possible.
The industry"s leading producers are Crown Bioscience, Charles River and ICON, with revenues of 18.32 percent, 13.86 percent and 9.13 percent in 2019.
This report aims to provide a comprehensive presentation of the global market for Oncology Based Preclinical CRO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oncology Based Preclinical CRO.
The Oncology Based Preclinical CRO market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Oncology Based Preclinical CRO market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oncology Based Preclinical CRO companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Crown Bioscience
Charles River
ICON
Eurofins Scientific
Taconic Biosciences
Covance
EVOTEC
The Jackson Laboratory
MI Bioresearch
Champion Oncology
Wuxi AppTec.
Xentech
Living Tumor Laboratory
Segment by Type
Blood Cancer
Solid Tumors
Others
Segment by Application
In Vitro
In Vivo
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oncology Based Preclinical CRO company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Preclinical research refers to before testing a drug in people, researchers must find out whether it has the potential to cause serious harm, also called toxicity. A Preclinical CRO, or preclinical contract research organization, provides the experience, knowledge, and skill required to take a pharmaceutical product or medical device from the drawing board to distribution. This journey entails a plethora of activities that involve scientists, medical personnel, administrators, governmental and industry liaisons, marketing experts, and a host of other technical and creative individuals. Rarely is this unique combination of credentials and craft already present within a sponsoring organization. The CRO industry emerged to fill this much-needed role, to provide the expertise required to bring a pharmaceutical product or medical device into the marketplace as quickly and smoothly as possible.
The industry"s leading producers are Crown Bioscience, Charles River and ICON, with revenues of 18.32 percent, 13.86 percent and 9.13 percent in 2019.
This report aims to provide a comprehensive presentation of the global market for Oncology Based Preclinical CRO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oncology Based Preclinical CRO.
The Oncology Based Preclinical CRO market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Oncology Based Preclinical CRO market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oncology Based Preclinical CRO companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Crown Bioscience
Charles River
ICON
Eurofins Scientific
Taconic Biosciences
Covance
EVOTEC
The Jackson Laboratory
MI Bioresearch
Champion Oncology
Wuxi AppTec.
Xentech
Living Tumor Laboratory
Segment by Type
Blood Cancer
Solid Tumors
Others
Segment by Application
In Vitro
In Vivo
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oncology Based Preclinical CRO company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oncology Based Preclinical CRO Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Blood Cancer
1.2.3 Solid Tumors
1.2.4 Others
1.3 Market by Application
1.3.1 Global Oncology Based Preclinical CRO Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 In Vitro
1.3.3 In Vivo
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Oncology Based Preclinical CRO Market Perspective (2020-2031)
2.2 Global Oncology Based Preclinical CRO Growth Trends by Region
2.2.1 Global Oncology Based Preclinical CRO Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Oncology Based Preclinical CRO Historic Market Size by Region (2020-2025)
2.2.3 Oncology Based Preclinical CRO Forecasted Market Size by Region (2026-2031)
2.3 Oncology Based Preclinical CRO Market Dynamics
2.3.1 Oncology Based Preclinical CRO Industry Trends
2.3.2 Oncology Based Preclinical CRO Market Drivers
2.3.3 Oncology Based Preclinical CRO Market Challenges
2.3.4 Oncology Based Preclinical CRO Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oncology Based Preclinical CRO Players by Revenue
3.1.1 Global Top Oncology Based Preclinical CRO Players by Revenue (2020-2025)
3.1.2 Global Oncology Based Preclinical CRO Revenue Market Share by Players (2020-2025)
3.2 Global Oncology Based Preclinical CRO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Oncology Based Preclinical CRO Revenue
3.4 Global Oncology Based Preclinical CRO Market Concentration Ratio
3.4.1 Global Oncology Based Preclinical CRO Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oncology Based Preclinical CRO Revenue in 2024
3.5 Global Key Players of Oncology Based Preclinical CRO Head office and Area Served
3.6 Global Key Players of Oncology Based Preclinical CRO, Product and Application
3.7 Global Key Players of Oncology Based Preclinical CRO, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Oncology Based Preclinical CRO Breakdown Data by Type
4.1 Global Oncology Based Preclinical CRO Historic Market Size by Type (2020-2025)
4.2 Global Oncology Based Preclinical CRO Forecasted Market Size by Type (2026-2031)
5 Oncology Based Preclinical CRO Breakdown Data by Application
5.1 Global Oncology Based Preclinical CRO Historic Market Size by Application (2020-2025)
5.2 Global Oncology Based Preclinical CRO Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Oncology Based Preclinical CRO Market Size (2020-2031)
6.2 North America Oncology Based Preclinical CRO Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Oncology Based Preclinical CRO Market Size by Country (2020-2025)
6.4 North America Oncology Based Preclinical CRO Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Oncology Based Preclinical CRO Market Size (2020-2031)
7.2 Europe Oncology Based Preclinical CRO Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Oncology Based Preclinical CRO Market Size by Country (2020-2025)
7.4 Europe Oncology Based Preclinical CRO Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Oncology Based Preclinical CRO Market Size (2020-2031)
8.2 Asia-Pacific Oncology Based Preclinical CRO Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Oncology Based Preclinical CRO Market Size by Region (2020-2025)
8.4 Asia-Pacific Oncology Based Preclinical CRO Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Oncology Based Preclinical CRO Market Size (2020-2031)
9.2 Latin America Oncology Based Preclinical CRO Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Oncology Based Preclinical CRO Market Size by Country (2020-2025)
9.4 Latin America Oncology Based Preclinical CRO Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oncology Based Preclinical CRO Market Size (2020-2031)
10.2 Middle East & Africa Oncology Based Preclinical CRO Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Oncology Based Preclinical CRO Market Size by Country (2020-2025)
10.4 Middle East & Africa Oncology Based Preclinical CRO Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Crown Bioscience
11.1.1 Crown Bioscience Company Details
11.1.2 Crown Bioscience Business Overview
11.1.3 Crown Bioscience Oncology Based Preclinical CRO Introduction
11.1.4 Crown Bioscience Revenue in Oncology Based Preclinical CRO Business (2020-2025)
11.1.5 Crown Bioscience Recent Development
11.2 Charles River
11.2.1 Charles River Company Details
11.2.2 Charles River Business Overview
11.2.3 Charles River Oncology Based Preclinical CRO Introduction
11.2.4 Charles River Revenue in Oncology Based Preclinical CRO Business (2020-2025)
11.2.5 Charles River Recent Development
11.3 ICON
11.3.1 ICON Company Details
11.3.2 ICON Business Overview
11.3.3 ICON Oncology Based Preclinical CRO Introduction
11.3.4 ICON Revenue in Oncology Based Preclinical CRO Business (2020-2025)
11.3.5 ICON Recent Development
11.4 Eurofins Scientific
11.4.1 Eurofins Scientific Company Details
11.4.2 Eurofins Scientific Business Overview
11.4.3 Eurofins Scientific Oncology Based Preclinical CRO Introduction
11.4.4 Eurofins Scientific Revenue in Oncology Based Preclinical CRO Business (2020-2025)
11.4.5 Eurofins Scientific Recent Development
11.5 Taconic Biosciences
11.5.1 Taconic Biosciences Company Details
11.5.2 Taconic Biosciences Business Overview
11.5.3 Taconic Biosciences Oncology Based Preclinical CRO Introduction
11.5.4 Taconic Biosciences Revenue in Oncology Based Preclinical CRO Business (2020-2025)
11.5.5 Taconic Biosciences Recent Development
11.6 Covance
11.6.1 Covance Company Details
11.6.2 Covance Business Overview
11.6.3 Covance Oncology Based Preclinical CRO Introduction
11.6.4 Covance Revenue in Oncology Based Preclinical CRO Business (2020-2025)
11.6.5 Covance Recent Development
11.7 EVOTEC
11.7.1 EVOTEC Company Details
11.7.2 EVOTEC Business Overview
11.7.3 EVOTEC Oncology Based Preclinical CRO Introduction
11.7.4 EVOTEC Revenue in Oncology Based Preclinical CRO Business (2020-2025)
11.7.5 EVOTEC Recent Development
11.8 The Jackson Laboratory
11.8.1 The Jackson Laboratory Company Details
11.8.2 The Jackson Laboratory Business Overview
11.8.3 The Jackson Laboratory Oncology Based Preclinical CRO Introduction
11.8.4 The Jackson Laboratory Revenue in Oncology Based Preclinical CRO Business (2020-2025)
11.8.5 The Jackson Laboratory Recent Development
11.9 MI Bioresearch
11.9.1 MI Bioresearch Company Details
11.9.2 MI Bioresearch Business Overview
11.9.3 MI Bioresearch Oncology Based Preclinical CRO Introduction
11.9.4 MI Bioresearch Revenue in Oncology Based Preclinical CRO Business (2020-2025)
11.9.5 MI Bioresearch Recent Development
11.10 Champion Oncology
11.10.1 Champion Oncology Company Details
11.10.2 Champion Oncology Business Overview
11.10.3 Champion Oncology Oncology Based Preclinical CRO Introduction
11.10.4 Champion Oncology Revenue in Oncology Based Preclinical CRO Business (2020-2025)
11.10.5 Champion Oncology Recent Development
11.11 Wuxi AppTec.
11.11.1 Wuxi AppTec. Company Details
11.11.2 Wuxi AppTec. Business Overview
11.11.3 Wuxi AppTec. Oncology Based Preclinical CRO Introduction
11.11.4 Wuxi AppTec. Revenue in Oncology Based Preclinical CRO Business (2020-2025)
11.11.5 Wuxi AppTec. Recent Development
11.12 Xentech
11.12.1 Xentech Company Details
11.12.2 Xentech Business Overview
11.12.3 Xentech Oncology Based Preclinical CRO Introduction
11.12.4 Xentech Revenue in Oncology Based Preclinical CRO Business (2020-2025)
11.12.5 Xentech Recent Development
11.13 Living Tumor Laboratory
11.13.1 Living Tumor Laboratory Company Details
11.13.2 Living Tumor Laboratory Business Overview
11.13.3 Living Tumor Laboratory Oncology Based Preclinical CRO Introduction
11.13.4 Living Tumor Laboratory Revenue in Oncology Based Preclinical CRO Business (2020-2025)
11.13.5 Living Tumor Laboratory Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oncology Based Preclinical CRO Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Blood Cancer
1.2.3 Solid Tumors
1.2.4 Others
1.3 Market by Application
1.3.1 Global Oncology Based Preclinical CRO Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 In Vitro
1.3.3 In Vivo
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Oncology Based Preclinical CRO Market Perspective (2020-2031)
2.2 Global Oncology Based Preclinical CRO Growth Trends by Region
2.2.1 Global Oncology Based Preclinical CRO Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Oncology Based Preclinical CRO Historic Market Size by Region (2020-2025)
2.2.3 Oncology Based Preclinical CRO Forecasted Market Size by Region (2026-2031)
2.3 Oncology Based Preclinical CRO Market Dynamics
2.3.1 Oncology Based Preclinical CRO Industry Trends
2.3.2 Oncology Based Preclinical CRO Market Drivers
2.3.3 Oncology Based Preclinical CRO Market Challenges
2.3.4 Oncology Based Preclinical CRO Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oncology Based Preclinical CRO Players by Revenue
3.1.1 Global Top Oncology Based Preclinical CRO Players by Revenue (2020-2025)
3.1.2 Global Oncology Based Preclinical CRO Revenue Market Share by Players (2020-2025)
3.2 Global Oncology Based Preclinical CRO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Oncology Based Preclinical CRO Revenue
3.4 Global Oncology Based Preclinical CRO Market Concentration Ratio
3.4.1 Global Oncology Based Preclinical CRO Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oncology Based Preclinical CRO Revenue in 2024
3.5 Global Key Players of Oncology Based Preclinical CRO Head office and Area Served
3.6 Global Key Players of Oncology Based Preclinical CRO, Product and Application
3.7 Global Key Players of Oncology Based Preclinical CRO, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Oncology Based Preclinical CRO Breakdown Data by Type
4.1 Global Oncology Based Preclinical CRO Historic Market Size by Type (2020-2025)
4.2 Global Oncology Based Preclinical CRO Forecasted Market Size by Type (2026-2031)
5 Oncology Based Preclinical CRO Breakdown Data by Application
5.1 Global Oncology Based Preclinical CRO Historic Market Size by Application (2020-2025)
5.2 Global Oncology Based Preclinical CRO Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Oncology Based Preclinical CRO Market Size (2020-2031)
6.2 North America Oncology Based Preclinical CRO Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Oncology Based Preclinical CRO Market Size by Country (2020-2025)
6.4 North America Oncology Based Preclinical CRO Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Oncology Based Preclinical CRO Market Size (2020-2031)
7.2 Europe Oncology Based Preclinical CRO Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Oncology Based Preclinical CRO Market Size by Country (2020-2025)
7.4 Europe Oncology Based Preclinical CRO Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Oncology Based Preclinical CRO Market Size (2020-2031)
8.2 Asia-Pacific Oncology Based Preclinical CRO Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Oncology Based Preclinical CRO Market Size by Region (2020-2025)
8.4 Asia-Pacific Oncology Based Preclinical CRO Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Oncology Based Preclinical CRO Market Size (2020-2031)
9.2 Latin America Oncology Based Preclinical CRO Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Oncology Based Preclinical CRO Market Size by Country (2020-2025)
9.4 Latin America Oncology Based Preclinical CRO Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oncology Based Preclinical CRO Market Size (2020-2031)
10.2 Middle East & Africa Oncology Based Preclinical CRO Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Oncology Based Preclinical CRO Market Size by Country (2020-2025)
10.4 Middle East & Africa Oncology Based Preclinical CRO Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Crown Bioscience
11.1.1 Crown Bioscience Company Details
11.1.2 Crown Bioscience Business Overview
11.1.3 Crown Bioscience Oncology Based Preclinical CRO Introduction
11.1.4 Crown Bioscience Revenue in Oncology Based Preclinical CRO Business (2020-2025)
11.1.5 Crown Bioscience Recent Development
11.2 Charles River
11.2.1 Charles River Company Details
11.2.2 Charles River Business Overview
11.2.3 Charles River Oncology Based Preclinical CRO Introduction
11.2.4 Charles River Revenue in Oncology Based Preclinical CRO Business (2020-2025)
11.2.5 Charles River Recent Development
11.3 ICON
11.3.1 ICON Company Details
11.3.2 ICON Business Overview
11.3.3 ICON Oncology Based Preclinical CRO Introduction
11.3.4 ICON Revenue in Oncology Based Preclinical CRO Business (2020-2025)
11.3.5 ICON Recent Development
11.4 Eurofins Scientific
11.4.1 Eurofins Scientific Company Details
11.4.2 Eurofins Scientific Business Overview
11.4.3 Eurofins Scientific Oncology Based Preclinical CRO Introduction
11.4.4 Eurofins Scientific Revenue in Oncology Based Preclinical CRO Business (2020-2025)
11.4.5 Eurofins Scientific Recent Development
11.5 Taconic Biosciences
11.5.1 Taconic Biosciences Company Details
11.5.2 Taconic Biosciences Business Overview
11.5.3 Taconic Biosciences Oncology Based Preclinical CRO Introduction
11.5.4 Taconic Biosciences Revenue in Oncology Based Preclinical CRO Business (2020-2025)
11.5.5 Taconic Biosciences Recent Development
11.6 Covance
11.6.1 Covance Company Details
11.6.2 Covance Business Overview
11.6.3 Covance Oncology Based Preclinical CRO Introduction
11.6.4 Covance Revenue in Oncology Based Preclinical CRO Business (2020-2025)
11.6.5 Covance Recent Development
11.7 EVOTEC
11.7.1 EVOTEC Company Details
11.7.2 EVOTEC Business Overview
11.7.3 EVOTEC Oncology Based Preclinical CRO Introduction
11.7.4 EVOTEC Revenue in Oncology Based Preclinical CRO Business (2020-2025)
11.7.5 EVOTEC Recent Development
11.8 The Jackson Laboratory
11.8.1 The Jackson Laboratory Company Details
11.8.2 The Jackson Laboratory Business Overview
11.8.3 The Jackson Laboratory Oncology Based Preclinical CRO Introduction
11.8.4 The Jackson Laboratory Revenue in Oncology Based Preclinical CRO Business (2020-2025)
11.8.5 The Jackson Laboratory Recent Development
11.9 MI Bioresearch
11.9.1 MI Bioresearch Company Details
11.9.2 MI Bioresearch Business Overview
11.9.3 MI Bioresearch Oncology Based Preclinical CRO Introduction
11.9.4 MI Bioresearch Revenue in Oncology Based Preclinical CRO Business (2020-2025)
11.9.5 MI Bioresearch Recent Development
11.10 Champion Oncology
11.10.1 Champion Oncology Company Details
11.10.2 Champion Oncology Business Overview
11.10.3 Champion Oncology Oncology Based Preclinical CRO Introduction
11.10.4 Champion Oncology Revenue in Oncology Based Preclinical CRO Business (2020-2025)
11.10.5 Champion Oncology Recent Development
11.11 Wuxi AppTec.
11.11.1 Wuxi AppTec. Company Details
11.11.2 Wuxi AppTec. Business Overview
11.11.3 Wuxi AppTec. Oncology Based Preclinical CRO Introduction
11.11.4 Wuxi AppTec. Revenue in Oncology Based Preclinical CRO Business (2020-2025)
11.11.5 Wuxi AppTec. Recent Development
11.12 Xentech
11.12.1 Xentech Company Details
11.12.2 Xentech Business Overview
11.12.3 Xentech Oncology Based Preclinical CRO Introduction
11.12.4 Xentech Revenue in Oncology Based Preclinical CRO Business (2020-2025)
11.12.5 Xentech Recent Development
11.13 Living Tumor Laboratory
11.13.1 Living Tumor Laboratory Company Details
11.13.2 Living Tumor Laboratory Business Overview
11.13.3 Living Tumor Laboratory Oncology Based Preclinical CRO Introduction
11.13.4 Living Tumor Laboratory Revenue in Oncology Based Preclinical CRO Business (2020-2025)
11.13.5 Living Tumor Laboratory Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Oncology Based Preclinical CRO Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Blood Cancer
Table 3. Key Players of Solid Tumors
Table 4. Key Players of Others
Table 5. Global Oncology Based Preclinical CRO Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Oncology Based Preclinical CRO Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Oncology Based Preclinical CRO Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Oncology Based Preclinical CRO Market Share by Region (2020-2025)
Table 9. Global Oncology Based Preclinical CRO Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Oncology Based Preclinical CRO Market Share by Region (2026-2031)
Table 11. Oncology Based Preclinical CRO Market Trends
Table 12. Oncology Based Preclinical CRO Market Drivers
Table 13. Oncology Based Preclinical CRO Market Challenges
Table 14. Oncology Based Preclinical CRO Market Restraints
Table 15. Global Oncology Based Preclinical CRO Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Oncology Based Preclinical CRO Market Share by Players (2020-2025)
Table 17. Global Top Oncology Based Preclinical CRO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Based Preclinical CRO as of 2024)
Table 18. Ranking of Global Top Oncology Based Preclinical CRO Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Oncology Based Preclinical CRO Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Oncology Based Preclinical CRO, Headquarters and Area Served
Table 21. Global Key Players of Oncology Based Preclinical CRO, Product and Application
Table 22. Global Key Players of Oncology Based Preclinical CRO, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Oncology Based Preclinical CRO Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Oncology Based Preclinical CRO Revenue Market Share by Type (2020-2025)
Table 26. Global Oncology Based Preclinical CRO Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Oncology Based Preclinical CRO Revenue Market Share by Type (2026-2031)
Table 28. Global Oncology Based Preclinical CRO Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Oncology Based Preclinical CRO Revenue Market Share by Application (2020-2025)
Table 30. Global Oncology Based Preclinical CRO Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Oncology Based Preclinical CRO Revenue Market Share by Application (2026-2031)
Table 32. North America Oncology Based Preclinical CRO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Oncology Based Preclinical CRO Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Oncology Based Preclinical CRO Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Oncology Based Preclinical CRO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Oncology Based Preclinical CRO Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Oncology Based Preclinical CRO Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Oncology Based Preclinical CRO Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Oncology Based Preclinical CRO Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Oncology Based Preclinical CRO Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Oncology Based Preclinical CRO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Oncology Based Preclinical CRO Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Oncology Based Preclinical CRO Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Oncology Based Preclinical CRO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Oncology Based Preclinical CRO Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Oncology Based Preclinical CRO Market Size by Country (2026-2031) & (US$ Million)
Table 47. Crown Bioscience Company Details
Table 48. Crown Bioscience Business Overview
Table 49. Crown Bioscience Oncology Based Preclinical CRO Product
Table 50. Crown Bioscience Revenue in Oncology Based Preclinical CRO Business (2020-2025) & (US$ Million)
Table 51. Crown Bioscience Recent Development
Table 52. Charles River Company Details
Table 53. Charles River Business Overview
Table 54. Charles River Oncology Based Preclinical CRO Product
Table 55. Charles River Revenue in Oncology Based Preclinical CRO Business (2020-2025) & (US$ Million)
Table 56. Charles River Recent Development
Table 57. ICON Company Details
Table 58. ICON Business Overview
Table 59. ICON Oncology Based Preclinical CRO Product
Table 60. ICON Revenue in Oncology Based Preclinical CRO Business (2020-2025) & (US$ Million)
Table 61. ICON Recent Development
Table 62. Eurofins Scientific Company Details
Table 63. Eurofins Scientific Business Overview
Table 64. Eurofins Scientific Oncology Based Preclinical CRO Product
Table 65. Eurofins Scientific Revenue in Oncology Based Preclinical CRO Business (2020-2025) & (US$ Million)
Table 66. Eurofins Scientific Recent Development
Table 67. Taconic Biosciences Company Details
Table 68. Taconic Biosciences Business Overview
Table 69. Taconic Biosciences Oncology Based Preclinical CRO Product
Table 70. Taconic Biosciences Revenue in Oncology Based Preclinical CRO Business (2020-2025) & (US$ Million)
Table 71. Taconic Biosciences Recent Development
Table 72. Covance Company Details
Table 73. Covance Business Overview
Table 74. Covance Oncology Based Preclinical CRO Product
Table 75. Covance Revenue in Oncology Based Preclinical CRO Business (2020-2025) & (US$ Million)
Table 76. Covance Recent Development
Table 77. EVOTEC Company Details
Table 78. EVOTEC Business Overview
Table 79. EVOTEC Oncology Based Preclinical CRO Product
Table 80. EVOTEC Revenue in Oncology Based Preclinical CRO Business (2020-2025) & (US$ Million)
Table 81. EVOTEC Recent Development
Table 82. The Jackson Laboratory Company Details
Table 83. The Jackson Laboratory Business Overview
Table 84. The Jackson Laboratory Oncology Based Preclinical CRO Product
Table 85. The Jackson Laboratory Revenue in Oncology Based Preclinical CRO Business (2020-2025) & (US$ Million)
Table 86. The Jackson Laboratory Recent Development
Table 87. MI Bioresearch Company Details
Table 88. MI Bioresearch Business Overview
Table 89. MI Bioresearch Oncology Based Preclinical CRO Product
Table 90. MI Bioresearch Revenue in Oncology Based Preclinical CRO Business (2020-2025) & (US$ Million)
Table 91. MI Bioresearch Recent Development
Table 92. Champion Oncology Company Details
Table 93. Champion Oncology Business Overview
Table 94. Champion Oncology Oncology Based Preclinical CRO Product
Table 95. Champion Oncology Revenue in Oncology Based Preclinical CRO Business (2020-2025) & (US$ Million)
Table 96. Champion Oncology Recent Development
Table 97. Wuxi AppTec. Company Details
Table 98. Wuxi AppTec. Business Overview
Table 99. Wuxi AppTec. Oncology Based Preclinical CRO Product
Table 100. Wuxi AppTec. Revenue in Oncology Based Preclinical CRO Business (2020-2025) & (US$ Million)
Table 101. Wuxi AppTec. Recent Development
Table 102. Xentech Company Details
Table 103. Xentech Business Overview
Table 104. Xentech Oncology Based Preclinical CRO Product
Table 105. Xentech Revenue in Oncology Based Preclinical CRO Business (2020-2025) & (US$ Million)
Table 106. Xentech Recent Development
Table 107. Living Tumor Laboratory Company Details
Table 108. Living Tumor Laboratory Business Overview
Table 109. Living Tumor Laboratory Oncology Based Preclinical CRO Product
Table 110. Living Tumor Laboratory Revenue in Oncology Based Preclinical CRO Business (2020-2025) & (US$ Million)
Table 111. Living Tumor Laboratory Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
Table 115. Authors List of This Report
List of Figures
Figure 1. Oncology Based Preclinical CRO Picture
Figure 2. Global Oncology Based Preclinical CRO Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Oncology Based Preclinical CRO Market Share by Type: 2024 VS 2031
Figure 4. Blood Cancer Features
Figure 5. Solid Tumors Features
Figure 6. Others Features
Figure 7. Global Oncology Based Preclinical CRO Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Oncology Based Preclinical CRO Market Share by Application: 2024 VS 2031
Figure 9. In Vitro Case Studies
Figure 10. In Vivo Case Studies
Figure 11. Oncology Based Preclinical CRO Report Years Considered
Figure 12. Global Oncology Based Preclinical CRO Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Oncology Based Preclinical CRO Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Oncology Based Preclinical CRO Market Share by Region: 2024 VS 2031
Figure 15. Global Oncology Based Preclinical CRO Market Share by Players in 2024
Figure 16. Global Top Oncology Based Preclinical CRO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Based Preclinical CRO as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Oncology Based Preclinical CRO Revenue in 2024
Figure 18. North America Oncology Based Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Oncology Based Preclinical CRO Market Share by Country (2020-2031)
Figure 20. United States Oncology Based Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Oncology Based Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Oncology Based Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Oncology Based Preclinical CRO Market Share by Country (2020-2031)
Figure 24. Germany Oncology Based Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Oncology Based Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Oncology Based Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Oncology Based Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Oncology Based Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Oncology Based Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Oncology Based Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Oncology Based Preclinical CRO Market Share by Region (2020-2031)
Figure 32. China Oncology Based Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Oncology Based Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Oncology Based Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Oncology Based Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Oncology Based Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Oncology Based Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Oncology Based Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Oncology Based Preclinical CRO Market Share by Country (2020-2031)
Figure 40. Mexico Oncology Based Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Oncology Based Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Oncology Based Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Oncology Based Preclinical CRO Market Share by Country (2020-2031)
Figure 44. Turkey Oncology Based Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Oncology Based Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Oncology Based Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Crown Bioscience Revenue Growth Rate in Oncology Based Preclinical CRO Business (2020-2025)
Figure 48. Charles River Revenue Growth Rate in Oncology Based Preclinical CRO Business (2020-2025)
Figure 49. ICON Revenue Growth Rate in Oncology Based Preclinical CRO Business (2020-2025)
Figure 50. Eurofins Scientific Revenue Growth Rate in Oncology Based Preclinical CRO Business (2020-2025)
Figure 51. Taconic Biosciences Revenue Growth Rate in Oncology Based Preclinical CRO Business (2020-2025)
Figure 52. Covance Revenue Growth Rate in Oncology Based Preclinical CRO Business (2020-2025)
Figure 53. EVOTEC Revenue Growth Rate in Oncology Based Preclinical CRO Business (2020-2025)
Figure 54. The Jackson Laboratory Revenue Growth Rate in Oncology Based Preclinical CRO Business (2020-2025)
Figure 55. MI Bioresearch Revenue Growth Rate in Oncology Based Preclinical CRO Business (2020-2025)
Figure 56. Champion Oncology Revenue Growth Rate in Oncology Based Preclinical CRO Business (2020-2025)
Figure 57. Wuxi AppTec. Revenue Growth Rate in Oncology Based Preclinical CRO Business (2020-2025)
Figure 58. Xentech Revenue Growth Rate in Oncology Based Preclinical CRO Business (2020-2025)
Figure 59. Living Tumor Laboratory Revenue Growth Rate in Oncology Based Preclinical CRO Business (2020-2025)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Table 1. Global Oncology Based Preclinical CRO Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Blood Cancer
Table 3. Key Players of Solid Tumors
Table 4. Key Players of Others
Table 5. Global Oncology Based Preclinical CRO Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Oncology Based Preclinical CRO Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Oncology Based Preclinical CRO Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Oncology Based Preclinical CRO Market Share by Region (2020-2025)
Table 9. Global Oncology Based Preclinical CRO Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Oncology Based Preclinical CRO Market Share by Region (2026-2031)
Table 11. Oncology Based Preclinical CRO Market Trends
Table 12. Oncology Based Preclinical CRO Market Drivers
Table 13. Oncology Based Preclinical CRO Market Challenges
Table 14. Oncology Based Preclinical CRO Market Restraints
Table 15. Global Oncology Based Preclinical CRO Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Oncology Based Preclinical CRO Market Share by Players (2020-2025)
Table 17. Global Top Oncology Based Preclinical CRO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Based Preclinical CRO as of 2024)
Table 18. Ranking of Global Top Oncology Based Preclinical CRO Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Oncology Based Preclinical CRO Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Oncology Based Preclinical CRO, Headquarters and Area Served
Table 21. Global Key Players of Oncology Based Preclinical CRO, Product and Application
Table 22. Global Key Players of Oncology Based Preclinical CRO, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Oncology Based Preclinical CRO Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Oncology Based Preclinical CRO Revenue Market Share by Type (2020-2025)
Table 26. Global Oncology Based Preclinical CRO Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Oncology Based Preclinical CRO Revenue Market Share by Type (2026-2031)
Table 28. Global Oncology Based Preclinical CRO Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Oncology Based Preclinical CRO Revenue Market Share by Application (2020-2025)
Table 30. Global Oncology Based Preclinical CRO Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Oncology Based Preclinical CRO Revenue Market Share by Application (2026-2031)
Table 32. North America Oncology Based Preclinical CRO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Oncology Based Preclinical CRO Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Oncology Based Preclinical CRO Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Oncology Based Preclinical CRO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Oncology Based Preclinical CRO Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Oncology Based Preclinical CRO Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Oncology Based Preclinical CRO Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Oncology Based Preclinical CRO Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Oncology Based Preclinical CRO Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Oncology Based Preclinical CRO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Oncology Based Preclinical CRO Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Oncology Based Preclinical CRO Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Oncology Based Preclinical CRO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Oncology Based Preclinical CRO Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Oncology Based Preclinical CRO Market Size by Country (2026-2031) & (US$ Million)
Table 47. Crown Bioscience Company Details
Table 48. Crown Bioscience Business Overview
Table 49. Crown Bioscience Oncology Based Preclinical CRO Product
Table 50. Crown Bioscience Revenue in Oncology Based Preclinical CRO Business (2020-2025) & (US$ Million)
Table 51. Crown Bioscience Recent Development
Table 52. Charles River Company Details
Table 53. Charles River Business Overview
Table 54. Charles River Oncology Based Preclinical CRO Product
Table 55. Charles River Revenue in Oncology Based Preclinical CRO Business (2020-2025) & (US$ Million)
Table 56. Charles River Recent Development
Table 57. ICON Company Details
Table 58. ICON Business Overview
Table 59. ICON Oncology Based Preclinical CRO Product
Table 60. ICON Revenue in Oncology Based Preclinical CRO Business (2020-2025) & (US$ Million)
Table 61. ICON Recent Development
Table 62. Eurofins Scientific Company Details
Table 63. Eurofins Scientific Business Overview
Table 64. Eurofins Scientific Oncology Based Preclinical CRO Product
Table 65. Eurofins Scientific Revenue in Oncology Based Preclinical CRO Business (2020-2025) & (US$ Million)
Table 66. Eurofins Scientific Recent Development
Table 67. Taconic Biosciences Company Details
Table 68. Taconic Biosciences Business Overview
Table 69. Taconic Biosciences Oncology Based Preclinical CRO Product
Table 70. Taconic Biosciences Revenue in Oncology Based Preclinical CRO Business (2020-2025) & (US$ Million)
Table 71. Taconic Biosciences Recent Development
Table 72. Covance Company Details
Table 73. Covance Business Overview
Table 74. Covance Oncology Based Preclinical CRO Product
Table 75. Covance Revenue in Oncology Based Preclinical CRO Business (2020-2025) & (US$ Million)
Table 76. Covance Recent Development
Table 77. EVOTEC Company Details
Table 78. EVOTEC Business Overview
Table 79. EVOTEC Oncology Based Preclinical CRO Product
Table 80. EVOTEC Revenue in Oncology Based Preclinical CRO Business (2020-2025) & (US$ Million)
Table 81. EVOTEC Recent Development
Table 82. The Jackson Laboratory Company Details
Table 83. The Jackson Laboratory Business Overview
Table 84. The Jackson Laboratory Oncology Based Preclinical CRO Product
Table 85. The Jackson Laboratory Revenue in Oncology Based Preclinical CRO Business (2020-2025) & (US$ Million)
Table 86. The Jackson Laboratory Recent Development
Table 87. MI Bioresearch Company Details
Table 88. MI Bioresearch Business Overview
Table 89. MI Bioresearch Oncology Based Preclinical CRO Product
Table 90. MI Bioresearch Revenue in Oncology Based Preclinical CRO Business (2020-2025) & (US$ Million)
Table 91. MI Bioresearch Recent Development
Table 92. Champion Oncology Company Details
Table 93. Champion Oncology Business Overview
Table 94. Champion Oncology Oncology Based Preclinical CRO Product
Table 95. Champion Oncology Revenue in Oncology Based Preclinical CRO Business (2020-2025) & (US$ Million)
Table 96. Champion Oncology Recent Development
Table 97. Wuxi AppTec. Company Details
Table 98. Wuxi AppTec. Business Overview
Table 99. Wuxi AppTec. Oncology Based Preclinical CRO Product
Table 100. Wuxi AppTec. Revenue in Oncology Based Preclinical CRO Business (2020-2025) & (US$ Million)
Table 101. Wuxi AppTec. Recent Development
Table 102. Xentech Company Details
Table 103. Xentech Business Overview
Table 104. Xentech Oncology Based Preclinical CRO Product
Table 105. Xentech Revenue in Oncology Based Preclinical CRO Business (2020-2025) & (US$ Million)
Table 106. Xentech Recent Development
Table 107. Living Tumor Laboratory Company Details
Table 108. Living Tumor Laboratory Business Overview
Table 109. Living Tumor Laboratory Oncology Based Preclinical CRO Product
Table 110. Living Tumor Laboratory Revenue in Oncology Based Preclinical CRO Business (2020-2025) & (US$ Million)
Table 111. Living Tumor Laboratory Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
Table 115. Authors List of This Report
List of Figures
Figure 1. Oncology Based Preclinical CRO Picture
Figure 2. Global Oncology Based Preclinical CRO Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Oncology Based Preclinical CRO Market Share by Type: 2024 VS 2031
Figure 4. Blood Cancer Features
Figure 5. Solid Tumors Features
Figure 6. Others Features
Figure 7. Global Oncology Based Preclinical CRO Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Oncology Based Preclinical CRO Market Share by Application: 2024 VS 2031
Figure 9. In Vitro Case Studies
Figure 10. In Vivo Case Studies
Figure 11. Oncology Based Preclinical CRO Report Years Considered
Figure 12. Global Oncology Based Preclinical CRO Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Oncology Based Preclinical CRO Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Oncology Based Preclinical CRO Market Share by Region: 2024 VS 2031
Figure 15. Global Oncology Based Preclinical CRO Market Share by Players in 2024
Figure 16. Global Top Oncology Based Preclinical CRO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Based Preclinical CRO as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Oncology Based Preclinical CRO Revenue in 2024
Figure 18. North America Oncology Based Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Oncology Based Preclinical CRO Market Share by Country (2020-2031)
Figure 20. United States Oncology Based Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Oncology Based Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Oncology Based Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Oncology Based Preclinical CRO Market Share by Country (2020-2031)
Figure 24. Germany Oncology Based Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Oncology Based Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Oncology Based Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Oncology Based Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Oncology Based Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Oncology Based Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Oncology Based Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Oncology Based Preclinical CRO Market Share by Region (2020-2031)
Figure 32. China Oncology Based Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Oncology Based Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Oncology Based Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Oncology Based Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Oncology Based Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Oncology Based Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Oncology Based Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Oncology Based Preclinical CRO Market Share by Country (2020-2031)
Figure 40. Mexico Oncology Based Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Oncology Based Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Oncology Based Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Oncology Based Preclinical CRO Market Share by Country (2020-2031)
Figure 44. Turkey Oncology Based Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Oncology Based Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Oncology Based Preclinical CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Crown Bioscience Revenue Growth Rate in Oncology Based Preclinical CRO Business (2020-2025)
Figure 48. Charles River Revenue Growth Rate in Oncology Based Preclinical CRO Business (2020-2025)
Figure 49. ICON Revenue Growth Rate in Oncology Based Preclinical CRO Business (2020-2025)
Figure 50. Eurofins Scientific Revenue Growth Rate in Oncology Based Preclinical CRO Business (2020-2025)
Figure 51. Taconic Biosciences Revenue Growth Rate in Oncology Based Preclinical CRO Business (2020-2025)
Figure 52. Covance Revenue Growth Rate in Oncology Based Preclinical CRO Business (2020-2025)
Figure 53. EVOTEC Revenue Growth Rate in Oncology Based Preclinical CRO Business (2020-2025)
Figure 54. The Jackson Laboratory Revenue Growth Rate in Oncology Based Preclinical CRO Business (2020-2025)
Figure 55. MI Bioresearch Revenue Growth Rate in Oncology Based Preclinical CRO Business (2020-2025)
Figure 56. Champion Oncology Revenue Growth Rate in Oncology Based Preclinical CRO Business (2020-2025)
Figure 57. Wuxi AppTec. Revenue Growth Rate in Oncology Based Preclinical CRO Business (2020-2025)
Figure 58. Xentech Revenue Growth Rate in Oncology Based Preclinical CRO Business (2020-2025)
Figure 59. Living Tumor Laboratory Revenue Growth Rate in Oncology Based Preclinical CRO Business (2020-2025)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Oral Antianginal Drugs Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Global Polyester BCF Yarns Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Global Glass Mat Reinforced Thermoplastics (GMT) for Automotive Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232